U2AF2
Splicing factor U2AF 65 kDa subunit
Also known as: U2AF2_HUMAN, U2AF65
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P26368
- Gene
- U2AF2
- Ensembl
- ENSG00000063244
- Chromosome
- 19
- Canonical length
- 475 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear speckles
OverviewNCBI Gene
U2 auxiliary factor (U2AF), comprised of a large and a small subunit, is a non-snRNP protein required for the binding of U2 snRNP to the pre-mRNA branch site. This gene encodes the U2AF large subunit which contains a sequence-specific RNA-binding region with 3 RNA recognition motifs and an Arg/Ser-rich domain necessary for splicing. The large subunit binds to the polypyrimidine tract of introns early during spliceosome assembly. Multiple transcript variants have been detected for this gene, but the full-length natures of only two have been determined to date. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
475 residues, UniProt reviewed canonical sequence.
>P26368|U2AF2
1 MSDFDEFERQ LNENKQERDK ENRHRKRSHS RSRSRDRKRR SRSRDRRNRD QRSASRDRRR
61 RSKPLTRGAK EEHGGLIRSP RHEKKKKVRK YWDVPPPGFE HITPMQYKAM QAAGQIPATA
121 LLPTMTPDGL AVTPTPVPVV GSQMTRQARR LYVGNIPFGI TEEAMMDFFN AQMRLGGLTQ
181 APGNPVLAVQ INQDKNFAFL EFRSVDETTQ AMAFDGIIFQ GQSLKIRRPH DYQPLPGMSE
241 NPSVYVPGVV STVVPDSAHK LFIGGLPNYL NDDQVKELLT SFGPLKAFNL VKDSATGLSK
301 GYAFCEYVDI NVTDQAIAGL NGMQLGDKKL LVQRASVGAK NATLVSPPST INQTPVTLQV
361 PGLMSSQVQM GGHPTEVLCL MNMVLPEELL DDEEYEEIVE DVRDECSKYG LVKSIEIPRP
421 VDGVEVPGCG KIFVEFTSVF DCQKAMQGLT GRKFANRVVV TKYCDPDSYH RRDFWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against U2AF2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 96 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 96 nTPM
- thymus: 86 nTPM
- spleen: 73 nTPM
- lymph node: 72 nTPM
- pituitary gland: 70 nTPM
- appendix: 68 nTPM
Single-cell type
- syncytiotrophoblasts: 83 nCPM
- oocytes: 78 nCPM
- migrating cytotrophoblasts: 76 nCPM
- extravillous trophoblasts: 73 nCPM
- cytotrophoblasts: 68 nCPM
- adrenal cortex cells: 64 nCPM
Immune cell
- neutrophil: 2.1 nTPM
- plasmacytoid DC: 1.7 nTPM
- intermediate monocyte: 1.4 nTPM
- gdT-cell: 1.2 nTPM
- non-classical monocyte: 1.2 nTPM
- classical monocyte: 1.1 nTPM
Brain region
- white matter: 66 nTPM
- medulla oblongata: 64 nTPM
- choroid plexus: 61 nTPM
- cerebellum: 60 nTPM
- thalamus: 57 nTPM
- cerebral cortex: 57 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about U2AF2.
Disease | AllUniProt
Conditions U2AF2 is implicated in, by any mechanism.
- Developmental delay, dysmorphic facies, and brain anomalies (DEVDFB) MIM:620535
Disease | GeneticClinVar
13 pathogenic / likely-pathogenic of 96 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Developmental delay, dysmorphic facies, and brain anomalies
- Inborn genetic diseases
- U2AF2-related neurodevelopmental disorder
- Neurodevelopmental disorder
- Leukodystrophy
Disease | ImmuneIEDB
Conditions an epitope on U2AF2 was assayed in.
- colon adenocarcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.71
- DepMap mean gene effect
- -1.43
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mRNA processing
- mRNA splicing, via spliceosome
- negative regulation of mRNA splicing, via spliceosome
- negative regulation of protein ubiquitination
- positive regulation of RNA splicing
- spliceosomal complex assembly
Molecular functions
- C2H2 zinc finger domain binding
- enzyme binding
- molecular function inhibitor activity
- poly-pyrimidine tract binding
- pre-mRNA 3'-splice site binding
- RNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- Nucleotide-binding alpha-beta plait domain superfamily
- RNA-binding domain superfamily
- RNA recognition motif
- U2 snRNP auxilliary factor, large subunit, splicing factor
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of U2AF2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads U2AF2 as an antibody target. Whether an autoantibody or antibody against U2AF2 could matter depends on whether native U2AF2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
U2AF2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label U2AF2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...